Dianthus Therapeutics DNTH
NASDAQ DNTH
$108.77 +0.92 (+0.85%)
As of: Sep 4, 2026 · 2:25 PM EDT

Dianthus Therapeutics (DNTH) EPS (Diluted) (2020 - 2025)

Analysis

Dianthus Therapeutics (DNTH) EPS (Diluted) (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 12.23
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 7.15
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.07 Bn 44.07 Bn - -3.06
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.42 Bn 27.58 Bn - 0.15
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -0.06
10 Dianthus Therapeutics 4.11 Bn 3.71 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -0.97
Jun 30, 2025 -0.88
Mar 31, 2025 -0.92
Dec 31, 2024 -0.84
Sep 30, 2024 -0.74
Jun 30, 2024 -0.65
Mar 31, 2024 -0.70
Dec 31, 2023 -2.04
Sep 30, 2023 -3.77
Jun 30, 2023 -2.93
Mar 31, 2023 -1.87
Dec 31, 2022 -2.71
Sep 30, 2022 -2.12
Jun 30, 2022 -4.70
Mar 31, 2022 -6.24
Dec 31, 2021 -5.62
Sep 30, 2021 -4.76
Jun 30, 2021 -5.04
Mar 31, 2021 -5.76
Dec 31, 2020 -6.62